Clinical Effectiveness of Intravitreal Fluocinolone Acetonide (FAc) (ILUVIEN™) in Patients with Diabetic Macular Oedema (DMO) Refractory to Prior Therapy: The Manchester Experience
Sign Up to like & getrecommendations! Published in 2019 at "Ophthalmology and Therapy"
DOI: 10.1007/s40123-019-0197-3
Abstract: IntroductionDiabetic macular oedema (DMO) remains a significant cause of sight loss in the UK. Despite macular laser and anti-VEGF agents, a large proportion of patients remain with persistent DMO. We present our results of using… read more here.
Keywords: acetonide fac; year; fluocinolone acetonide; macular oedema ... See more keywords